New Study Reveals Real-World Outcomes After Discontinuing GLP-1 Weight Loss Medications
A study from Cleveland Clinic indicates that many patients maintain stable weight after stopping GLP-1 medications, sugg...
Found 188 results
A study from Cleveland Clinic indicates that many patients maintain stable weight after stopping GLP-1 medications, sugg...
A recent study reveals that the combination of excess abdominal fat and reduced muscle mass considerably heightens morta...
A recent study indicates a short-term fasting mimicking diet significantly improves symptoms and inflammation in Crohn’s...
A study reveals that combining specific plant compounds can significantly enhance anti-inflammatory effects, offering in...
New research reveals genetic variants involved in GLP-1 resistance may impact treatment efficacy for diabetes medication...
Recent research reveals distinct health risks posed by obesity in men and women, emphasizing the necessity of gender-spe...
New research links certain IBS medications, particularly antidepressants, to increased mortality risk, urging patients t...
Metabolic dysfunction-associated steatotic liver disease is now the most common liver condition worldwide, affecting abo...
Recent research reveals that everyday physical activity promotes brain health by influencing the movement of cerebrospin...
As older adults increasingly turn to cannabis, Stanford experts highlight significant health risks and key consideration...
New research redefines the role of senescent cells, suggesting they can be both harmful and beneficial, leading to innov...
Research suggests that GLP-1 medications, commonly used for weight loss, might also help reduce inflammation in arthriti...
A recent study indicates Wegovy, a leading weight loss drug, has a heightened association with a rare eye condition that...
A Brazilian study highlights omega-3 fish oil's potential in mitigating insulin resistance in non-obese type 2 diabetes,...
Research suggests GLP-1 medications may reduce addiction risks and improve treatment outcomes, opening avenues for dual-...
New research indicates that GLP-1 medications like Ozempic and Wegovy may lower breast cancer risk by 30%, urging furthe...
New research highlights how genetic variants may prevent some patients from responding effectively to GLP-1 agonists lik...
New findings from a study show significant patterns in the stoppage and restart of GLP-1 medications among Type 2 diabet...
Researchers discover that terpenes from cannabis can alleviate chronic pain, such as fibromyalgia and post-surgical disc...
Ebola and hantavirus pose significant health risks, sharing similar early symptoms but differing in transmission and tre...